Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 58 % of short-term debt in 2025; threshold 65 %.
Financials
Financial year 2025
APOTHEEK REYSKENS from Gingelom, company number BE0459506123, closed financial year 2025 with a result of € 79,550 after tax. For that financial year APOTHEEK REYSKENS recorded a gross margin of € 150,138 and equity of € 109,596. Compared with financial year 2024, the result moved from € 84,123 to € 79,550. The company is profitable. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on July 29, 2026.
€ 109,596
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 79,550
▼ 5% vs 2024
Profit after tax over the fiscal year.
€ 77,920
▲ 6% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 79,500 paid out
100 % of the profit went to the shareholders, mostly to REYSKENS LIESBETH MANAGEMENT (100 % of the shares). That is where the money ends up.
People and assets in 2025
0.1
▼ 0.1 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 12,531
▼ 4% vs 2024
Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 7,168
▲ € 6,848 vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 306,650
▼ 10% vs 2024
€ 35,278 is repaid this year. At this pace the long-term loan is gone in ≈ 9 years.
€ 66,585
▲ 4% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 1,457
▲ 176% vs 2024
Wages, holiday pay and social contributions still to pay. No outstanding taxes.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 141,567 | € 114,160 | € 163,274 | € 150,138 | ▼ 8% |
| Profit after taxes | € 63,079 | € 32,715 | € 84,123 | € 79,550 | ▼ 5% |
| Equity | € 79,207 | € 79,422 | € 109,546 | € 109,596 | |
| Total debts | € 618,139 | € 577,110 | € 557,246 | € 543,368 | ▼ 2% |
| Cash | € 59,387 | € 33,497 | € 73,259 | € 77,920 | ▲ 6% |
| Land & buildings | € 450,149 | € 419,020 | € 377,538 | € 338,770 | ▼ 10% |
| Retained profit | € 66,807 | € 67,022 | € 97,146 | € 97,196 | |
| Dividend | € 62,800 | € 32,500 | € 54,000 | € 79,500 | ▲ 47% |
| Bank debt | € 417,800 | € 380,101 | € 341,018 | € 306,650 | ▼ 10% |
| Balance sheet total | € 697,346 | € 656,533 | € 666,792 | € 652,964 | ▼ 2% |
| Employees (FTE) | 0.2 | 0.2 | 0.2 | 0.1 | ▼ 0.1 |
Key figures of APOTHEEK REYSKENS, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to APOTHEEK REYSKENS?
What happened at APOTHEEK REYSKENS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 79,550 (▼ 5% vs 2024). Source: NBB ↗
- New establishment in Gingelom. KBO
- Start of the company according to the CBE. KBO
In short
From € 63,079 profit in 2022 to € 79,550 profit in 2025.
Paid € 20,470 in corporate taxes since 2022.
Best year ever: 2024, with € 84,123 profit.
Paid out € 228,800 in dividends to the owners in total.
A new publication or filing at APOTHEEK REYSKENS? We notify you, reason included.
Follow APOTHEEK REYSKENSDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of REYSKENS LIESBETH MANAGEMENT comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
APOTHEEK REYSKENSBehind APOTHEEK REYSKENS is Reyskens Liesbeth Management BV. The shares are held by REYSKENS LIESBETH MANAGEMENT (100%).
Directors
According to the 2025 annual accounts
Reyskens Liesbeth Management BV
Director · represented by Reyskens Liesbeth
Shareholders
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Homsemstraat 1A
3891 Gingelom
Homsemstraat 1 A
3891 Gingelom
Active since 11 March 1997
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Website
Technologies
Hosting & Email
Email provider
Self-hosted
Hosting
CLOUDFLARENET - Cloudflare, Inc., US
DNS
Cloudflare DNS
Website info
Features
Security
Network
Details
- Company number
- 0459.506.123
- VAT number
- BE 0459.506.123
- Registered office
- Homsemstraat 1A, 3891 Gingelom
- Names & denominations
- APOTHEEK REYSKENS
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 19 December 1996
- Peppol
- Active · Active since 26 Jun 2025
- Contact
- apotheekreyskens.be
- Activities · NACE
Detailhandel in farmaceutische producten
Apothekers